Related Experiment Videos
Phosphorylation and chronic agonist treatment atypically modulate GABAB receptor cell surface stability
Benjamin P Fairfax1, Julie A Pitcher, Mark G H Scott
1Medical Research Council Laboratory of Molecular Cell Biology and Department of Pharmacology, University College London, London WC1E 6BT, United Kingdom.
The Journal of Biological Chemistry
|January 7, 2004
Summary
GABA(B) receptors are stable on neuron surfaces, with baclofen promoting degradation, not endocytosis. Phosphorylation of GABA(B)R2 stabilizes these receptors, impacting synaptic inhibition.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- GABA(B) receptors are crucial for slow synaptic inhibition in the central nervous system.
- Their cell surface stability is vital for modulating receptor signaling but remains poorly understood.
- Understanding GABA(B) receptor dynamics is key to comprehending neuronal communication.
Purpose of the Study:
- To investigate the mechanisms controlling GABA(B) receptor cell surface stability in neurons.
- To determine the role of agonist exposure and phosphorylation in GABA(B) receptor trafficking and degradation.
- To elucidate how signaling pathways influence GABA(B) receptor availability and synaptic inhibition.
Main Methods:
- Utilized cultured cortical and hippocampal neurons to study GABA(B) receptor behavior.
- Examined receptor endocytosis and degradation following baclofen exposure.
- Investigated agonist-induced phosphorylation and arrestin recruitment in heterologous systems.
- Analyzed the impact of cAMP-dependent protein kinase and beta-adrenergic receptor co-stimulation.
Main Results:
- GABA(B) receptors exhibit remarkable stability at the plasma membrane with minimal basal endocytosis.
- Baclofen, a GABA(B) receptor agonist, did not enhance receptor endocytosis in neurons.
- Chronic baclofen exposure promoted endocytosis-independent GABA(B) receptor degradation.
- Increased degradation correlated with reduced phosphorylation at serine 892 in GABA(B)R2.
Conclusions:
- GABA(B) receptor phosphorylation, particularly at serine 892, stabilizes surface receptors in neurons.
- Baclofen induces GABA(B) receptor degradation through an endocytosis-independent pathway.
- Signaling pathways regulating cAMP levels significantly influence GABA(B) receptor availability and tonic synaptic inhibition.